Phathom Pharmaceuticals I... (PHAT)

AI Score

Unlock

4.59

-0.18 (-3.77%)

At close: Apr 16, 2025, 9:55 AM

Phathom Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018
Cash & Equivalents	297.26M	334.68M	276.24M	322.23M	381.39M	213.68M	248.85M	129.57M	155.38M	196.84M	207.39M	138.09M	183.26M	224.62M	209.67M	237.97M	287.5M	226.36M	247.27M	256.67M	243.76M	74.48M	82.92M	-879K	879K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.76M	n/a
Long-Term Investments	n/a	n/a	2.86M	2.87M	2.86M	2.86M	528K	n/a	505K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	16.09M	10.73M	8.86M	10.09M	9.93M	3.75M	3.75M	804K	299K	1.78M	805K	805K	341K	341K	291K	385K	384K	381K	381K	381K	181K	2.01M	337K	-879K	n/a
Receivables	38.8M	21.05M	10.88M	3.88M	1.64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	82K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	3.21M	3.11M	2.18M	1.46M	1.21M	111K	111K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-82K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-19K
Other Current Assets	20.87M	14.98M	15.5M	12.75M	13.19M	12.94M	8.76M	10.27M	5.13M	975K	1.86M	7.65M	3.27M	695K	1.67M	4.84M	3.87M	800K	1.41M	n/a	11.84M	3.17M	n/a	n/a	n/a
Total Current Assets	360.13M	373.82M	304.79M	340.31M	397.43M	226.73M	257.72M	139.84M	160.51M	196.84M	209.26M	145.74M	186.53M	225.31M	211.34M	242.81M	291.37M	227.16M	248.68M	261.83M	255.6M	77.65M	84.54M	879K	902K
Property-Plant & Equipment	2.09M	2.49M	2.86M	3.23M	3.62M	3.66M	3.04M	3.36M	3.49M	3.31M	3.44M	2.5M	2.56M	2.72M	2.95M	3.17M	3.36M	3.35M	3.36M	1.71M	1.4M	40K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	18.18M	13.22M	14.59M	16.18M	16.41M	10.27M	7.32M	4.17M	4.3M	5.09M	4.25M	3.31M	2.9M	3.06M	3.24M	3.55M	3.74M	3.73M	3.74M	2.09M	1.58M	2.05M	337K	-879K	n/a
Total Assets	378.32M	387.04M	319.38M	356.5M	413.84M	236.99M	265.04M	144.01M	164.81M	201.93M	213.5M	149.05M	189.43M	228.38M	214.58M	246.36M	295.11M	230.89M	252.42M	263.92M	257.18M	79.71M	84.88M	n/a	902K
Account Payables	10.51M	7.13M	7.66M	8.4M	12.6M	5.79M	4.17M	4.73M	10M	7.13M	5.76M	2.86M	5.15M	5.58M	5.4M	10.86M	16.78M	4.79M	4.89M	1.19M	699K	439K	450K	n/a	55K
Deferred Revenue	n/a	n/a	n/a	n/a	18.34M	15.1M	16.41M	n/a	n/a	n/a	-559K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.48M	4.45M	1.96M	n/a	n/a
Short-Term Debt	n/a	n/a	9.91M	16.48M	n/a	n/a	n/a	n/a	n/a	n/a	628K	490K	n/a	484K	10.82M	12.24M	7.35M	5.99M	1.8M	148K	n/a	95.23M	92.74M	n/a	1.95M
Other Current Liabilities	36.44M	57.48M	n/a	n/a	12.14M	10.16M	10.12M	3.49M	n/a	945K	8.86M	4.96M	n/a	16.5M	19.02M	15.44M	n/a	14M	4.63M	2.45M	413K	107.37M	49.6M	n/a	n/a
Total Current Liabilities	85.73M	65.29M	47.01M	43.46M	38.78M	23.98M	21.55M	14.44M	26.24M	22.88M	21.07M	11.39M	18.92M	27.81M	39.61M	40.84M	55.52M	27.67M	13.26M	4.58M	3.75M	207.49M	144.75M	n/a	2.19M
Long-Term Debt	201.41M	175.73M	495.61M	451.55M	137.84M	99.26M	97.81M	96.64M	95.26M	93.88M	92.43M	91.04M	89.67M	88.31M	37.34M	35.59M	39.63M	41.06M	44.87M	45.91M	22.78M	22.61M	22.45M	n/a	n/a
Other Long-Term Liabilities	344.76M	333.14M	10.45M	9.7M	309.52M	130.9M	127.3M	122.18M	117.03M	110.35M	105.6M	7.5M	7.5M	7.5M	4.13M	4.13M	4.13M	4.13M	4.13M	4.13M	2.06M	2.06M	2.06M	n/a	n/a
Total Long-Term Liabilities	546.17M	508.87M	506.2M	461.54M	447.82M	230.79M	225.89M	219.76M	213.39M	205.47M	199.43M	99.62M	98.35M	97.08M	42.84M	41.18M	45.32M	46.83M	50.74M	50.64M	25.48M	24.67M	24.51M	n/a	n/a
Total Liabilities	631.9M	574.16M	553.21M	505M	486.6M	254.76M	247.44M	234.21M	239.62M	228.35M	220.5M	111.01M	117.28M	124.9M	82.45M	82.02M	100.84M	74.5M	64M	55.22M	29.22M	232.17M	169.26M	n/a	2.19M
Total Debt	201.91M	176.41M	506.38M	469.05M	139.03M	100.61M	99.31M	98.3M	97.07M	95.81M	94.45M	92.61M	91.34M	90.07M	49.54M	49.3M	49.02M	48.69M	48.42M	46.67M	23.57M	117.84M	115.19M	n/a	1.95M
Common Stock	6K	6K	5K	5K	5K	5K	5K	4K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	2K	2K	n/a	n/a	n/a	n/a
Retained Earnings	-1.26B	-1.19B	-1.1B	-1.01B	-928.68M	-849.12M	-805.87M	-764.91M	-727.09M	-672.05M	-620.96M	-570.03M	-529.37M	-493.54M	-456.88M	-420.33M	-385.49M	-331.77M	-297.66M	-276.56M	-256.42M	-158.41M	-90.3M	n/a	-1.29M
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	0.00	-0.00	0.00	0.00	n/a	n/a	n/a	n/a	n/a	-1.29M	n/a
Shareholders Equity	-253.58M	-187.11M	-233.83M	-148.5M	-72.76M	-17.77M	17.6M	-90.19M	-74.81M	-26.42M	-7M	38.03M	72.16M	103.48M	132.13M	164.34M	194.27M	156.39M	188.42M	208.69M	227.96M	-152.46M	-84.39M	-1.29M	-1.29M
Total Investments	n/a	n/a	2.86M	2.87M	2.86M	2.86M	528K	n/a	505K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.76M	n/a